1Comi AM, Zimmerman A W, Frye VH, et al. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism.]. Child Neurol. 1999;14(6) :388-394.
2Atladottir HO, Pedersen MG, Thorsen P, et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics,2009;124(2) :687-694.
3Libbey JE, Coon HH, Kirkman NJ , et al. Are there altered an?tibody responses to measles, mumps, or rubella viruses in au?tism? J. Neurovirol. 2007;13(3) :252-259.
4Rout UK,Dhossche DM.A pathogenetic model of autism invol?ving Purkinjecell loss through anti - GAD antibodies. Med. Hypotheses,2008;71 (2) :218-221.
5Mostafa GA,AL-Ayadhi LY. The possible link between the el?evated serum levels of neurokinin A and anti - ribosomal P protein antibodies in children with autism. J. Neuroinflamma?tion,2011;8: 180.
7Vojdani A, Mumper E,Granpeesheh D,et al. Low natural kil?ler cytotoxic activity in autism: the role of glutathione, IL - 2 and IL-15. J. Neuroimmunol,2008;205(1-2) :148-154.
8Brown AC, Mehl- Madrona L. Autoimmune and gastrointestinal dysfunctions: does a subset of children with autism reveal a broader connection? Expert Rev. Gastroenterol. Hepatol. 2011;5(4) :465-477.
9Wasilewska J, Kaczmarski M, Stasiak - Barmuta A, et al. Low serum IgA and increased expression of CD23 on B lympho?cytes in peripheral blood in children with regressive autism aged 3-6 years old. Arch Med Sci. 2012;8(2) :324-331.
10MolloyCA,Morrow AL,Meinzen-Derr J ,et al. Elevated cyto?kine levels in children with autism spectrum disorder. J. Neuroimmunol. 2006; 172(1-2): 198-205.
